Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Neurovascular Devices Market by Type (Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices), By Application (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Neurovascular Devices Market by Type (Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices), By Application (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131817 3300 Medical Devices & Consumables 377 246 Pages 4.7 (48)
                                          

The global neurovascular devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of neurological disorders and rising demand for minimally invasive procedures. The major players in the global neurovascular devices market are Boston Scientific Corporation, Abbott Laboratories, Medtronic plc., Stryker Corporation, Terumo Corporation and others. -The Neurovascular Devices market is expected to grow at a CAGR of 5.5% from 2017 to 2022. -The Neurovascular Devices market is driven by the increasing prevalence of neurological disorders, such as stroke and Alzheimer's disease, which are leading to an increased demand for neurovascular devices. -Increasing incidence rates of neurological disorders are also driving the growth of the Neurovascular Devices market. For instance, in 2016, there were approximately 6 million new cases of dementia worldwide and this number is expected to increase by more than 50% by 2030. The global prevalence rate for dementia was estimated at 4% in 2010 and it is projected that it will reach 7% in 2030. This increase in incidence rates will lead to an increased demand for neurovascular devices over the forecast period (2017 - 2022). -In addition, technological advancements have led to improved design and performance features that have made these devices more effective than ever before. These factors are also driving the growth of this market over the forecast period (2017 - 2022).

Industry Growth Insights published a new data on “Neurovascular Devices Market”. The research report is titled “Neurovascular Devices Market research by Types (Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices), By Applications (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis), By Players/Companies Stryker Corporation, Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, W.L. Gore & Associates, Acandis”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Neurovascular Devices Market Research Report

By Type

Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices

By Application

Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis

By Companies

Stryker Corporation, Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, W.L. Gore & Associates, Acandis

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

246

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Neurovascular Devices Industry Outlook


Global Neurovascular Devices Market Report Segments:

The global Neurovascular Devices market is segmented on the basis of:

Types

Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Stryker Corporation
  2. Medtronic
  3. Johnson & Johnson
  4. Terumo Corporation
  5. Penumbra
  6. Integer Holdings Corporation
  7. Microport Scientific Corporation
  8. Merit Medical Systems
  9. W.L. Gore & Associates
  10. Acandis

Global Neurovascular Devices Market Overview


Highlights of The Neurovascular Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Embolization Devices
    2. Revascularization Devices
    3. Accessory Devices
    4. Thrombectomy Devices
    5. Embolic Protection Devices
  1. By Application:

    1. Aneurysm
    2. Arteriovenous Malformation and Fistulas (AVM)
    3. Ischemic Stroke
    4. Stenosis
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Neurovascular Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Neurovascular Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Neurovascular Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Neurovascular Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Neurovascular Devices Market - Supply Chain
   4.5. Global Neurovascular Devices Market Forecast
      4.5.1. Neurovascular Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Neurovascular Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Neurovascular Devices Market Absolute $ Opportunity

5. Global Neurovascular Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Neurovascular Devices Market Size and Volume Forecast by Type
      5.3.1. Embolization Devices
      5.3.2. Revascularization Devices
      5.3.3. Accessory Devices
      5.3.4. Thrombectomy Devices
      5.3.5. Embolic Protection Devices
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Neurovascular Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Neurovascular Devices Market Size and Volume Forecast by Application
      6.3.1. Aneurysm
      6.3.2. Arteriovenous Malformation and Fistulas (AVM)
      6.3.3. Ischemic Stroke
      6.3.4. Stenosis
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Neurovascular Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Neurovascular Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Neurovascular Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Neurovascular Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Neurovascular Devices Demand Share Forecast, 2019-2029

9. North America Neurovascular Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Neurovascular Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Neurovascular Devices Market Size and Volume Forecast by Application
      9.4.1. Aneurysm
      9.4.2. Arteriovenous Malformation and Fistulas (AVM)
      9.4.3. Ischemic Stroke
      9.4.4. Stenosis
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Neurovascular Devices Market Size and Volume Forecast by Type
      9.7.1. Embolization Devices
      9.7.2. Revascularization Devices
      9.7.3. Accessory Devices
      9.7.4. Thrombectomy Devices
      9.7.5. Embolic Protection Devices
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Neurovascular Devices Demand Share Forecast, 2019-2029

10. Latin America Neurovascular Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Neurovascular Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Neurovascular Devices Market Size and Volume Forecast by Application
      10.4.1. Aneurysm
      10.4.2. Arteriovenous Malformation and Fistulas (AVM)
      10.4.3. Ischemic Stroke
      10.4.4. Stenosis
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Neurovascular Devices Market Size and Volume Forecast by Type
      10.7.1. Embolization Devices
      10.7.2. Revascularization Devices
      10.7.3. Accessory Devices
      10.7.4. Thrombectomy Devices
      10.7.5. Embolic Protection Devices
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Neurovascular Devices Demand Share Forecast, 2019-2029

11. Europe Neurovascular Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Neurovascular Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Neurovascular Devices Market Size and Volume Forecast by Application
      11.4.1. Aneurysm
      11.4.2. Arteriovenous Malformation and Fistulas (AVM)
      11.4.3. Ischemic Stroke
      11.4.4. Stenosis
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Neurovascular Devices Market Size and Volume Forecast by Type
      11.7.1. Embolization Devices
      11.7.2. Revascularization Devices
      11.7.3. Accessory Devices
      11.7.4. Thrombectoy Devices
      11.7.5. Embolic Protection Devices
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Neurovascular Devices Demand Share, 2019-2029

12. Asia Pacific Neurovascular Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Neurovascular Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Neurovascular Devices Market Size and Volume Forecast by Application
      12.4.1. Aneurysm
      12.4.2. Arteriovenous Malformation and Fistulas (AVM)
      12.4.3. Ischemic Stroke
      12.4.4. Stenosis
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Neurovascular Devices Market Size and Volume Forecast by Type
      12.7.1. Embolization Devices
      12.7.2. Revascularization Devices
      12.7.3. Accessory Devices
      12.7.4. Thrombectomy Devices
      12.7.5. Embolic Protection Devices
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Neurovascular Devices Demand Share, 2019-2029

13. Middle East & Africa Neurovascular Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Neurovascular Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Neurovascular Devices Market Size and Volume Forecast by Application
      13.4.1. Aneurysm
      13.4.2. Arteriovenous Malformation and Fistulas (AVM)
      13.4.3. Ischemic Stroke
      13.4.4. Stenosis
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Neurovascular Devices Market Size and Volume Forecast by Type
      13.7.1. Embolization Devices
      13.7.2. Revascularization Devices
      13.7.3. Accessory Devices
      13.7.4. Thrombectomy Devices
      13.7.5. Embolic Protection Devices
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Neurovascular Devices Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Neurovascular Devices Market: Market Share Analysis
   14.2. Neurovascular Devices Distributors and Customers
   14.3. Neurovascular Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Stryker Corporation
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Medtronic
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Johnson & Johnson
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Terumo Corporation
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Penumbra
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Integer Holdings Corporation
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Microport Scientific Corporation
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Merit Medical Systems
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. W.L. Gore & Associates
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Acandis
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us